Back to Search
Start Over
Verapamil, neuromuscular transmission and the nicotinic receptor.
- Source :
-
European journal of pharmacology [Eur J Pharmacol] 1988 Jul 07; Vol. 151 (2), pp. 301-6. - Publication Year :
- 1988
-
Abstract
- The effect of verapamil on neuromuscular transmission was studied in the frog by analysing ionophoretic endplate current (iEPC) trains and the growth and decay phases of miniature endplate currents (mepcs). In addition, single channel data on the interaction of verapamil with the nicotinic acetylcholine receptor were obtained from cultured embryonic chick skeletal muscle cells. Verapamil caused both open and closed channel blockade in the iEPC trains. Mepc amplitude was decreased at low micromolar concentrations, and at higher concentrations there was also accelerated mepc decay indicating open channel blockade. The latter effect could not be explained by a sequential channel occlusion mechanism. Analysis of the mepc rising phase showed that low micromolar concentrations of the drug decreased the pool of receptors which could be activated. Single channel data confirmed the specific interaction of verapamil with the nicotinic receptor, showing closed channel blockade at low concentrations, and at higher levels the shortening of open channel lifetime. It is suggested that both forms of blockade may involve desensitization processes.
- Subjects :
- Animals
Anura
Calcium Channels drug effects
Calcium Channels physiology
Cells, Cultured
Chick Embryo
In Vitro Techniques
Muscles drug effects
Muscles innervation
Muscles physiology
Neuromuscular Junction physiology
Receptors, Nicotinic physiology
Neuromuscular Junction drug effects
Receptors, Nicotinic drug effects
Synaptic Transmission drug effects
Verapamil pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 0014-2999
- Volume :
- 151
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- European journal of pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 2844556
- Full Text :
- https://doi.org/10.1016/0014-2999(88)90812-6